Page last updated: 2024-12-05

stenopril

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Stenopril (also known as telmisartan) is an angiotensin II receptor blocker (ARB) used to treat high blood pressure. It works by blocking the action of angiotensin II, a hormone that narrows blood vessels. This helps lower blood pressure and reduce the risk of stroke, heart attack, and other cardiovascular problems. Telmisartan is synthesized through a multi-step process involving several organic reactions, such as the formation of a tetrazole ring and a benzimidazole ring. Its effects are primarily attributed to its ability to block the AT1 receptor, which is responsible for mediating the effects of angiotensin II. Telmisartan is studied extensively due to its clinical benefits in managing hypertension and its potential application in other cardiovascular diseases. It is also being investigated for its potential role in preventing kidney disease, reducing the risk of dementia, and improving metabolic syndrome.'

stenopril: RN given refers to parent cpd; stenopril refers to the HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5025
SCHEMBL ID18645287
MeSH IDM0087897

Synonyms (13)

Synonym
benzenepropanamine, n-(1-methyl-2-phenylethyl)-
alpha-methyl-n-(3-phenylpropyl)phenethylamine
stenopril
13005-65-7
1-phenyl-n-(3-phenylpropyl)propan-2-amine
AKOS005359132
cas_131443
bdbm85392
nsc_131443
ppap, (-)
SCHEMBL18645287
3-phenyl-n-(1-phenylpropan-2-yl)propan-1-amine
DTXSID80926577
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID493017Wombat Data for BeliefDocking1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Identification and exploitation of the sigma-opiate pharmacophore.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]